Balancing benefits and risks: bevacizumab's role in postoperative recovery after spinal oncologic neurosurgery
{{output}}
Background: Spinal oncologic neurosurgery presents considerable therapeutic challenges. Bevacizumab, a monoclonal antibody targeting VEGF, has shown potential to reduce tumor vascularity and postoperative fibrosis. However, its p... ...
